Boothbay Fund Management, LLC Biotechnology

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
INSM
Insmed Inc
CALL
$19.3 Million
265K
Q3 2024
Added 225.86%
VKTX
Viking Therapeutics, Inc.
CALL
$18.4 Million
290K
Q2 2024
Added 428.44%
VRTX
Vertex Pharmaceuticals Inc
PUT
$14.2 Million
30.6K
Q2 2022
Added 69.09%
VRTX
Vertex Pharmaceuticals Inc
CALL
$14.2 Million
30.6K
Q2 2022
Added 69.09%
APLT
Applied Therapeutics Inc.
PUT
$12.1 Million
1.43M
Q4 2023
New holding
JANX
Janux Therapeutics, Inc.
PUT
$4.84 Million
107K N/A
IMVT
Immunovant, Inc.
CALL
$4.13 Million
150K
Q2 2024
Reduced 0.34%
CLDX
Celldex Therapeutics, Inc.
CALL
$3.06 Million
90.2K
Q1 2023
Reduced 37.4%
CLDX
Celldex Therapeutics, Inc.
PUT
$3.06 Million
90.2K
Q1 2023
Reduced 37.4%
BGNE
Bei Gene, Ltd.
CALL
$2.04 Million
9.1K
Q3 2024
New holding
CORT
Corcept Therapeutics Inc
PUT
$1.68 Million
36.3K
Q3 2024
New holding
AKRO
Akero Therapeutics, Inc.
PUT
$1.67 Million
58.1K
Q3 2023
New holding
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$1.49 Million
7K
Q1 2022
Closed
DYN
Dyne Therapeutics, Inc.
PUT
$1.39 Million
38.8K
Q4 2023
New holding
CAPR
Capricor Therapeutics, Inc.
PUT
$1.33 Million
87.7K
Q3 2024
New holding
CAPR
Capricor Therapeutics, Inc.
CALL
$1.33 Million
87.7K
Q3 2024
New holding
VRDN
Viridian Therapeutics, Inc.\De
CALL
$1.33 Million
58.5K
Q3 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.
CALL
$1.27 Million
44K
Q1 2024
Added 96.15%
CORT
Corcept Therapeutics Inc
CALL
$1.25 Million
27K
Q3 2024
New holding
BDTX
Black Diamond Therapeutics, Inc.
PUT
$1.24 Million
285K
Q4 2023
Added 18.02%
BDTX
Black Diamond Therapeutics, Inc.
CALL
$920,000
212K
Q4 2023
Added 18.02%
CYTK
Cytokinetics Inc
CALL
$807,000
15.3K
Q3 2024
Reduced 2.35%
SANA
Sana Biotechnology, Inc.
CALL
$790,000
190K N/A
SANA
Sana Biotechnology, Inc.
PUT
$790,000
190K N/A
IOVA
Iovance Biotherapeutics, Inc.
CALL
$664,000
70.8K
Q1 2022
Closed
RCUS
Arcus Biosciences, Inc.
CALL
$507,000
33.2K
Q3 2024
Added 408.82%
SRRK
Scholar Rock Holding Corp
CALL
$471,000
58.9K
Q2 2024
Reduced 37.02%
SRRK
Scholar Rock Holding Corp
PUT
$471,000
58.9K
Q2 2024
Reduced 37.02%
FULC
Fulcrum Therapeutics, Inc.
CALL
$460,000
129K
Q3 2024
New holding
PCVX
Vaxcyte, Inc.
PUT
$411,000
3.6K
Q3 2023
Added 10.16%
SWTX
Spring Works Therapeutics, Inc.
CALL
$410,000
12.8K
Q3 2023
New holding
GALT
Galectin Therapeutics Inc
PUT
$402,000
146K
Q4 2023
New holding
GALT
Galectin Therapeutics Inc
CALL
$402,000
146K
Q4 2023
New holding
PYXS
Pyxis Oncology, Inc.
CALL
$363,000
99.1K
Q3 2024
Reduced 42.41%
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$336,000
63.8K
Q2 2022
Closed
ALEC
Alector, Inc.
CALL
$207,000
44.4K
Q3 2021
Closed
BMEA
Biomea Fusion, Inc.
PUT
$156,000
15.5K
Q2 2023
Added 24.15%
QURE
Uni Qure N.V.
CALL
$155,000
31.5K
Q3 2024
Reduced 41.87%
Filter Shares Options
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email